⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Relmada Therapeutics, Inc. Common Stock

$4.57
+0.49 (+12.14%)

Volume:

2.492M ($11.30M)

Market Capitalization:

$487.47M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Relmada Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

+0.05(+1.10%)
Open$4.52
Close$4.57
Low$4.46
Low Change-0.06 (-1.33%)
High$4.61
High Change+0.09 (+1.99%)
Range$0.15
Volume232.143K
Dollar Volume$1.06M

Regular Trading Hours

-0.07(-1.52%)
Open$4.60
Close$4.53
Low$4.30
Low Change-0.31 (-6.63%)
High$4.65
High Change+0.05 (+1.09%)
Range$0.36
Volume2.224M
Dollar Volume$10.07M

Premarket

+0.34(+7.98%)
Open$4.26
Close$4.60
Low$4.26
Low Change0.00 (0.00%)
High$4.71
High Change+0.45 (+10.59%)
Range$0.45
Volume35.871K
Dollar Volume$165.01K

After Hours Yesterday

+0.03(+0.74%)
Open$4.07
Close$4.10
Low$4.07
Low Change0.00 (0.00%)
High$4.10
High Change+0.03 (+0.74%)
Range$0.03
Volume157.135K
Dollar Volume$644.25K

Regular Trading Hours Yesterday

-0.18(-4.12%)
Open$4.25
Close$4.08
Low$4.00
Low Change-0.25 (-5.88%)
High$4.25
High Change+0.00 (+0.00%)
Range$0.25
Volume2.647M
Dollar Volume$10.79M

Premarket Yesterday

+0.00(+0.00%)
Open$4.20
Close$4.20
Low$4.20
Low Change0.00 (0.00%)
High$4.20
High Change+0.00 (+0.00%)
Range$0.00
Volume142
Dollar Volume$596.40

Relmada Therapeutics Top Trades

Relmada Therapeutics's top trade so far today returned +10.59%, while the top short trade returned -8.83%.

Relmada Therapeutics Moving Averages

5 Day Moving Average (SMA5)$4.25
10 Day Moving Average (SMA10)$4.35
20 Day Moving Average (SMA20)$4.53
50 Day Moving Average (SMA50)$5.14
100 Day Moving Average (SMA100)$6.04
200 Day Moving Average (SMA200)$5.48

Relmada Therapeutics Statistics

Average Volume (30 Days)1.12M
P/E Ratio (Current)-7.05
EPS (Current)-$0.58
Dividend Yield0.00%
Free Cash Flow-$45.99M
Cash Ratio1.53
Current Ratio29.52
Quick Ratio29.52
Debt to Equity0.00
Enterprise Value$424.95M
EV to EBITDA-6.52
EV to Sales
Price to Book2.11
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.28%
Return on Equity-0.30%

Relmada Therapeutics Stock Splits

There have been 2 stock splits for Relmada Therapeutics (RLMD). The last reverse stock split occured on September 30, 2019 and reduced the outstanding shares at a ratio of 4:1.

DateTypeRatio
Sep 30, 2019Reverse4:1
Aug 12, 2015Reverse5:1

Relmada Therapeutics Dividends

There have been no dividends for Relmada Therapeutics (RLMD).